Evidence map›Paper›PMID 33440207›Full record

Observational studyThe Journal of infection2021

Incidence, risk factors, and thrombotic load of pulmonary embolism in patients hospitalized for COVID-19 infection.

Alberto García-Ortega, Grace Oscullo, Pilar Calvillo, Raquel López-Reyes, Raúl Méndez, José Daniel Gómez-Olivas, Amina Bekki, Carles Fonfría, Laura Trilles-Olaso, Enrique Zaldívar and 15 more

Open access · bronzeAbstract readObservational Study
In one paragraph

Observational study in The Journal of infection, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 28 papers, 4 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
28citing papers in PubMed, 4 pooled it
3.1field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

28 citing papers in PubMed, 4 syntheses or guidelines pooled it, 49 citations in OpenAlex.

  1. Pooled it
  2. Predictive scores for the diagnosis of Pulmonary Embolism in COVID-19: A systematic review.International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases · 2022
    Pooled it
  3. Pooled it
  4. Pooled it
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Review
  11. Article
  12. Article
  13. Review
  14. Review
  15. Article
  16. Review
  17. Article
  18. Article
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

25 authors at 4 institutions in 1 country.

Alberto García-OrtegaRespiratory Department, Hospital Universitario y Politécnico La Fe, Valencia, Spain; Medical Research Institute Hospital La Fe (IISLAFE), Valencia, Spain. Electronic address: albortgva@gmail.com.
Grace OsculloRespiratory Department, Hospital Universitario y Politécnico La Fe, Valencia, Spain; Medical Research Institute Hospital La Fe (IISLAFE), Valencia, Spain.
Pilar CalvilloRadiology Department, Hospital Universitario y Politécnico La Fe, Valencia, Spain.
Raquel López-ReyesRespiratory Department, Hospital Universitario y Politécnico La Fe, Valencia, Spain; Medical Research Institute Hospital La Fe (IISLAFE), Valencia, Spain.
Raúl MéndezRespiratory Department, Hospital Universitario y Politécnico La Fe, Valencia, Spain; Medical Research Institute Hospital La Fe (IISLAFE), Valencia, Spain.
José Daniel Gómez-OlivasRespiratory Department, Hospital Universitario y Politécnico La Fe, Valencia, Spain.
Amina BekkiRespiratory Department, Hospital Universitario y Politécnico La Fe, Valencia, Spain.
Carles FonfríaRadiology Department, Hospital Universitario y Politécnico La Fe, Valencia, Spain.
Laura Trilles-OlasoRadiology Department, Hospital Universitario y Politécnico La Fe, Valencia, Spain.
Enrique ZaldívarRespiratory Department, Hospital Universitario y Politécnico La Fe, Valencia, Spain; Medical Research Institute Hospital La Fe (IISLAFE), Valencia, Spain.
Ana FerrandoRespiratory Department, Hospital Universitario y Politécnico La Fe, Valencia, Spain.
Gabriel AngueraRespiratory Department, Hospital Universitario y Politécnico La Fe, Valencia, Spain; Lung Transplantation Unit, Hospital Universitario y Politécnico La Fe, Valencia, Spain.
Andrés Briones-GómezRespiratory Department, Hospital Universitario y Politécnico La Fe, Valencia, Spain.
Juan Pablo Reig-MezquidaRespiratory Department, Hospital Universitario y Politécnico La Fe, Valencia, Spain; Lung Transplantation Unit, Hospital Universitario y Politécnico La Fe, Valencia, Spain.
Laura FecedRespiratory Department, Hospital Universitario y Politécnico La Fe, Valencia, Spain; Medical Research Institute Hospital La Fe (IISLAFE), Valencia, Spain.
Paula González-JiménezRespiratory Department, Hospital Universitario y Politécnico La Fe, Valencia, Spain; Medical Research Institute Hospital La Fe (IISLAFE), Valencia, Spain.
Soledad ReyesRespiratory Department, Hospital Universitario y Politécnico La Fe, Valencia, Spain.
Carlos F Muñoz-NúñezRadiology Department, Hospital Universitario y Politécnico La Fe, Valencia, Spain.
Ainhoa CarreresRadiology Department, Hospital Universitario y Politécnico La Fe, Valencia, Spain.
Ricardo GilInternal Medicine, Hospital Universitario y Politécnico La Fe, Valencia, Spain.
Carmen MorataInternal Medicine, Hospital Universitario y Politécnico La Fe, Valencia, Spain.
Nuria Toledo-PonsDepartment of Pneumology, University Hospital Son Espases, Palma de Mallorca, Spain.
Luis Martí-BonmatiRadiology Department, Hospital Universitario y Politécnico La Fe, Valencia, Spain; Biomedical Imaging Research Group (GIBI230), Instituto de Investigación Sanitaria La Fe, Valencia, Spain.
Rosario MenéndezRespiratory Department, Hospital Universitario y Politécnico La Fe, Valencia, Spain; Medical Research Institute Hospital La Fe (IISLAFE), Valencia, Spain; Medicine Faculty, University of Valencia, Valencia, Spain; CIBER de enfermedades respiratorias, Instituto Carlos III, Madrid, Spain.
Miguel Ángel Martínez-GarcíaRespiratory Department, Hospital Universitario y Politécnico La Fe, Valencia, Spain; Medical Research Institute Hospital La Fe (IISLAFE), Valencia, Spain; CIBER de enfermedades respiratorias, Instituto Carlos III, Madrid, Spain.
Hospital Universitari i Politècnic La Fe · ESInstituto de Investigación Sanitaria La Fe · ESHospital Universitario Son Espases · ESUniversitat de València · ES

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectiveTo determine the incidence, characteristics, and risk factors of pulmonary embolism (PE) among patients hospitalized for COVID-19. PATIENTS AND

methodsWe performed a prospective observational study of a randomly selected cohort of consecutive patients hospitalized for COVID-19 infection between March 8, 2020 through April 25, 2020. All eligible patients underwent a computed tomography pulmonary angiography independently of their PE clinical suspicion and were pre-screened for a baseline elevated D-dimer level.

results119 patients were randomly selected from the 372 admitted to one tertiary hospital in Valencia (Spain) for COVID-19 infection during the period of study. Seventy-three patients fulfilled both the inclusion criteria and none of the exclusion criteria and were finally included in the study. Despite a high level of pharmacological thromboprophylaxis (89%), the incidence of PE was 35.6% (95% confidence interval [CI], 29.6 to 41.6%), mostly with a peripheral location and low thrombotic load (Qanadli score 18.5%). Multivariate analysis showed that heart rate (Hazard Ratio [HR], 1.04), room-air oxygen saturation (spO2) (HR, 0.87), D-dimer (HR, 1.02), and C-reactive protein (CRP) levels (HR, 1.01) at the time of admission were independent predictors of incident PE during hospitalization. A risk score was constructed with these four variables showing a high predictive value of incident PE (AUC-ROC: 0.86; 95% CI: 0.80 to 0.93).

conclusionsOur findings confirmed a high incidence of PE in hospitalized COVID-19 patients. Heart rate, spO2, D-dimer, and CRP levels at admission were associated with higher rates of PE during hospitalization.

Indexed as

Pulmonary EmbolismVenous ThromboembolismAgedAnticoagulantsCOVID-19FemaleFibrin Fibrinogen Degradation ProductsHospitalizationHumansIncidenceMaleMiddle AgedProspective StudiesRisk FactorsSpainAnticoagulantsFibrin Fibrinogen Degradation ProductsComputed tomographyCOVID-19InflammationPulmonary embolismThrombosis

Identifiers

PMID33440207
PMCPMC7834386
OpenAlexW3120108250

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.